443 filings
6-K
CLLS
Cellectis
2 May 24
Cellectis Appoints Arthur Stril as Interim Chief Financial Officer
8:03pm
20-F
2023 FY
CLLS
Cellectis
Annual report (foreign)
29 Apr 24
5:01pm
6-K
CLLS
Cellectis
22 Apr 24
Cellectis Presents Novel TALENĀ® Editing Processes Enabling Highly Efficient Gene Correction and Gene Insertion in HSPCs
4:35pm
6-K
CLLS
Cellectis
10 Apr 24
Cellectis Publishes a Novel Intronic Gene Editing Approach For the Treatment of Inborn Metabolic Diseases by Edited HSPCs
4:35pm
6-K
CLLS
Cellectis
8 Apr 24
Current report (foreign)
4:35pm
SC 13G/A
9uwrskmgxl
14 Feb 24
Cellectis / Long Focus Capital Management ownership change
5:07pm
SC 13G/A
q8isb5e
14 Feb 24
Cellectis / PFIZER ownership change
2:24pm
6-K
pe1 n8bi675a5tq
16 Jan 24
Current report (foreign)
4:45pm
6-K
9ult4vja0i23 0rozly
22 Dec 23
Current report (foreign)
4:35pm
6-K
45kfsw7 duxcug3p
22 Dec 23
Current report (foreign)
4:01pm
6-K
i2f82ma 75ei9
5 Dec 23
Current report (foreign)
4:01pm
SC 13G/A
v72wi9i33 8bme28
5 Dec 23
Cellectis / BAILLIE GIFFORD & CO ownership change
7:18am
6-K
35fu2h8h phcb2
17 Nov 23
Current report (foreign)
4:56pm
6-K
7ihhdyq9jj0l
17 Nov 23
Current report (foreign)
4:35pm
SC 13D/A
t0w63bu 4bfd42
16 Nov 23
Cellectis / ASTRAZENECA ownership change
11:16am
6-K
q4mvz2m
15 Nov 23
Cellectis Announces the execution of the Subsequent Investment Agreement with AstraZeneca
7:48am
SC 13D/A
qrj7on 5asxjkb
13 Nov 23
Cellectis / Bpifrance Participations ownership change
3:04pm
SC 13D
rdh9rnu 35gju2a
9 Nov 23
Cellectis / ASTRAZENECA ownership change
5:07pm
6-K
xoe2frw
9 Nov 23
Joint Researchand Collaboration Agreement
4:01pm
6-K
v8qkh6ku yo
6 Nov 23
Cellectis Reports Financial Results for Third Quarter and First Nine Months 2023
4:35pm